A detailed history of Inscription Capital, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Inscription Capital, LLC holds 827 shares of VRTX stock, worth $372,952. This represents 0.06% of its overall portfolio holdings.

Number of Shares
827
Previous 837 1.19%
Holding current value
$372,952
Previous $392,000 2.04%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$460.0 - $505.78 $4,600 - $5,057
-10 Reduced 1.19%
827 $384,000
Q2 2024

Jul 17, 2024

BUY
$392.81 - $485.53 $108,022 - $133,520
275 Added 48.93%
837 $392,000
Q1 2024

Jul 17, 2024

BUY
$407.69 - $446.08 $229,121 - $250,696
562 New
562 $234,000
Q4 2023

Jan 18, 2024

BUY
$343.0 - $410.68 $192,766 - $230,802
562 New
562 $228,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.